Roger Tung to receive 2009 Mass High Tech All Star award for his contributions to pharmaceutical industry

Concert Pharmaceuticals, Inc. announced today that Roger Tung, Ph.D., President and Chief Executive Officer, has been named a 2009 Mass High Tech All Star for his contributions to the pharmaceutical industry. The annual All Star awards honor pioneers and leaders across several business and technology sectors in New England. This year’s honorees will be profiled in a special supplement in the November 4 edition of Mass High Tech: The Journal of New England Technology.

“Roger has become a true leader in the biotech community and is a very deserving recipient of this award. As a scientist, he has a remarkable track record of discovering and developing novel drugs for diseases such as HIV, Hepatitis C, and cystic fibrosis. While building on that success at Concert, he has also proven to be a terrific entrepreneur, leading a fast growing and exciting new company,” said Richard H. Aldrich, Chairman of the Board of Concert Pharmaceuticals.

“I am honored to be recognized by Mass High Tech with this award,” said Dr. Roger Tung. “This award is a tribute to all of Concert’s employees who are advancing a new branch of chemistry that we believe will enable the rapid discovery and development of clinically and commercially important new medicines.”